Pharmaceuticals Tenders in Germany | Government Procurement

Registration, quality assurance and the shape of a medicines contract

A medicines tender is decided on quality assurance before it is decided on price. Bidders must show that the product is authorised or registered for use in the destination market, that it is manufactured at a site holding current good manufacturing practice certification, and -- for many donor-funded and essential medicines programmes -- that the product or its manufacturer appears on a recognised prequalification list. These are documentary conditions of admissibility assessed against the specific product and manufacturing site offered, and a change of site after award is a contractual event, not an administrative one.

Products are specified by international non-proprietary name, strength and dosage form so that generics compete openly, with pharmacopoeial standards cited for quality. Delivery conditions carry as much weight as the product: a minimum proportion of shelf life remaining on arrival, batch certificates of analysis, tamper-evident and correctly labelled packaging in the required language, and unbroken cold chain with temperature monitoring for products that need it. A consignment that arrives with too little shelf life left is routinely rejected at the buyer's cost to the supplier.

The commercial structure is usually a framework at agreed unit prices with call-offs against forecast rather than firm volume, because demand depends on disease patterns and programme funding. That places emphasis on lead times, on the supplier's obligation to hold or replenish stock, and on what happens in a shortage -- allocation, substitution and notification terms are increasingly explicit. Recall capability is tested rather than assumed: buyers ask how quickly a batch can be traced and withdrawn from every facility it reached.

This section describes how this category is bought generally, across the public buyers that publish it. The figures elsewhere on this page are measured for this market alone.

Who buys pharmaceuticals in Germany?

GlobalGov holds 4,115 pharmaceuticals records from 720 distinct buying organisations in Germany. The most frequent publishers are KKH Kaufmännische Krankenkasse (304 records); AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse (289 records); DAK-Gesundheit (262 records); AOK Bayern - Die Gesundheitskasse (206 records); Techniker Krankenkasse (191 records); AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen (189 records). Between them the 6 largest account for 35% of everything published, so buying here is spread across many separate authorities.

Buying organisation	Records	Share
KKH Kaufmännische Krankenkasse	304	7.4%
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse	289	7.0%
DAK-Gesundheit	262	6.4%
AOK Bayern - Die Gesundheitskasse	206	5.0%
Techniker Krankenkasse	191	4.6%
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen	189	4.6%

What are pharmaceuticals contracts worth in Germany?

546 of the 4,115 records publish a contract value. The median is $1 and the largest single published value is $1.7B. By size, 359 under $100k, 69 between $100k and $1M, 92 between $1M and $10M, 26 above $10M. The remaining 3,569 publish no value at all, so every figure here describes the priced subset only, and values are as stated by the buyer rather than as finally awarded.

Contract size	Records	Share of priced
under $100k	359	66%
between $100k and $1M	69	13%
between $1M and $10M	92	17%
above $10M	26	4.8%

How long do bidders get to respond to pharmaceuticals tenders in Germany?

Across the 552 Germany pharmaceuticals notices that publish both a publication date and a closing date, the median response window is 35 days. A quarter of them allowed 32 days or fewer and a quarter stayed open for more than 44. Short turnarounds are the exception rather than the rule here: only 3 (0.5%) closed within a fortnight of being published.

How often are pharmaceuticals tenders published in Germany?

Germany publishes about 72 notices a month in this category, 863 in the last twelve months. That is 28% fewer than the 1,192 published in the twelve months before that. Over the last three years there were 3,126, spread across 69 separate months of activity since 25 June 2016. May is historically the busiest month. The most recent was published 21 September 2026.

How does Germany compare with other pharmaceuticals markets?

Among the 39 countries where GlobalGov holds a comparable pharmaceuticals market, Germany ranks 1st by number of records. No other country in the corpus publishes more of it. Within Germany itself, pharmaceuticals is the 14th largest of the 76 procurement categories tracked here.

Where do the Germany pharmaceuticals records on this page come from?

These 4,115 records are collected from 2 official sources: TED (4,048), DTVP (67). GlobalGov is an independent aggregator and is not affiliated with any of them; each record links back to the notice on its issuing portal. The set is rebuilt nightly, and the counts on this page were taken on 2026-10-01.

Open Pharmaceuticals tenders in Germany

Showing 10 of the 1,336 notices open in this category today. Openness uses the same definition as the Germany market page: active, not marked awarded, cancelled, closed or expired, and either closing in the future or published within the last 90 days with no stated closing date.